Drug Target Review – Issue 4 2019
This issue includes a discussion on the future of high-throughput screening through collaboration, an analysis of mass spectrometry as a structural biology tool and an exploration of the challenges of hit-to-lead when researching tropical diseases. Also in the issue are articles on immuno-oncology and assays.
Included in this issue:
CRISPR: kick‑starting the revolution in drug discovery
Dr Pushpanathan Muthuirulan, Harvard University
Antibody characterisation – an essential researchers’ resource
Dr Tara Hiltke, National Cancer Institute
A novel approach to unravelling the mysteries of Alzheimer’s
Professor Tuomas Knowles, University of Cambridge
Dr Sean Devenish, Fluidic Analytics
- PERSONALISED MEDICINE
Getting precise: how humanised models aid in biologics drug discovery
Paul Volden, Taconic Biosciences
Transitioning novel peptide hits into lead compounds
Steven A Trim, Venomtech
Dr Carol M Trim, Canterbury Christ Church University
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!